Dan OliverCEO and Founder at Rejuvenate Bio, USASpeaker
Agenda Sessions
PANEL DISCUSSION: Preparing for the Future of ATMP Commercialization & Attracting Investment to Avoid Roadblocks
, 4:30pmView SessionCase Study: A Liver Directed Gene Therapy Program Targeting FGF21
, 11:00amView Session